Weill Cornell Medicine researchers have designed an AI system that could help clinical laboratories identify...
Discover our interdisciplinary PhD programs and collaborative Tri-Institutional programs designed to foster research excellence.
Discover our MS programs from Biomedical Imaging to Genetic Counseling.
Driven by Education.
Powered by Faculty.Built for your future.
Powered by Faculty.Built for your future.
Weill Cornell is unique in how focused it is on medical science research. There is no other institution where I can so easily find professors to collaborate with for clinical research.
Austin Varela
Alumni
Weill Cornell's program stood out to me as uniquely well-structured, balancing coursework and research alongside affiliations with leading institutions like Memorial Sloan Kettering.
Sanjhna Saravanan
Student
My favorite part of Weill Cornell is the sense of community within the graduate school and the research institutions: students and faculty are genuinely interested in supporting one another.
Nora Pyenson
Alumni
The spirit of collaboration between and within the partnership of Weill Cornell Medicine and the Sloan Kettering Institute is a strength of Weill Cornell Graduate School.
Joan Massagué
Faculty
WCGS News
Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine.
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators.